Twitter Facebook Linkedin Plusone Pinterest Email

Sanjay Dhar, M.Phil., Ph.D.A leader and highly skilled researcher with more than 17 years of R&D experience in pre-clinical, and clinical environments with a strong focus on cell and molecular biology, regenerative medicine, tissue engineering, oncology, biochemistry, immunology and genetic engineering with special emphasis on cell-based product and therapeutic applications. Oncological applications included establishing markers for breast and prostate cancer. Possess a strong experience in industry, academics and investor relations. As an industry expert in stem cell and platelet rich plasma sciences/applications for more than 19 years, established proprietary protocols for stem cell (ASC) and platelet rich plasma (PRP) isolations with highest efficacy and efficient time management. Both the protocols are FDA compliant. Stem cell isolation technique is enzyme treatment free and the platelet isolation is based on density gradient-based differential centrifugation. Expertise in vitro and in vivo (animal) experiments and laboratory management experiences. Exhibited successful leadership experience in research and clinical project management, data collection, and analysis. Expert in writing technical, KOL, patent, and research documents. A leader in new product development with special emphasis on cell technologies and biomedical engineering. Have a proven record of managing, collaborating, and leading various professionals like students, residents, faculties, scientists, and engineers from inter –or intra departmental projects. Have also led the collaboration between academics, industries, and industry-academic joint ventures like KOLs, CROs, and research grants. Experience in establishing proof of concept, investigative tasks, and motivating staff to attain goals. Well-versed with investor relations including communications with investors, presentations, and following the company’s financial strategy. Also versed with supply chain management, QA/QC, customer relation and acquisition, new product, and entity launches. Familiar with mergers & acquisitions as I was part of the group which was involved in the company going public.

SKILLS

  • One of the first to isolate and validate the existence of stem cells in adipose tissue (ASC)
  • Isolation of platelet-rich plasma (PRP)
  • All types of primary human cell lines & tissue cultures and validations and media optimizations
  • Cell-based protein isolation, assay, and characterization
  • Cell-based therapeutic applications
  • Well versed with most of the cell & molecular biology, biochemical, immunological, gene modification, viral vectors and transgene techniques
  • Stem cell differentiation in multi-potent lineages
  • Writing of KOLs studies, in vitro and in vivo study protocols, IACUCs, IRBs, technical bulletins, research publications, white papers
  • Design, execute, manage and lead multiple projects (technical, financial, performance, etc.) in a timely and efficient manner, e.g., KOL and CRO projects
  • Experience in training the sales and marketing personal about product science and mechanism of action to be presented to various outlets (physicians, companies, etc.)
  • Product packing, presentation, marketing, launch, regulatory compliance, and sales 2
  • Have both academic and industry experiences in all aspects of bench and clinical research
  • End to End product development and life cycle management
  • Fully versed with cGLP, cGMP, QA/QC, and data and supply chain management
  • Skilled in product and business development both laterally and vertically
  • Training of sales and marketing force about the product